Secondary prevention after intracerebral haemorrhage.

Maddalena ToffaliFederico CarboneEnrico FainardiMorotti Andrea Fabrizio Montecucco Luca LiberaleAlessandro Padovani

Published in: European journal of clinical investigation (2023)

Appropriate recognition and treatment of modifiable risk factors for ICH recurrence might improve outcomes in ICH survivors. Ongoing randomized trials might provide novel insights and improve long-term management.

Keyphrases

young adults
type diabetes
combination therapy
skeletal muscle
replacement therapy